Richard Bungay

Richard Edward Bungay is currently Director at Chroma Therapeutics Ltd. since 2004, Secretary & Director at Macrotarg Ltd. since 2011, Non-Executive Director at Nasdaq Corporate Solutions International Ltd., Non-Executive Director at Cambridge Cognition Holdings Plc since 2020, Secretary & Director at Diurnal Ltd., Director at Monument Therapeutics Ltd., and Chief Operating Officer at Sitala Bio Ltd. Former roles include Chief Executive Officer at Imophoron Ltd. from 2022 to 2024, Chief Financial Officer & Executive Director at Immedica Group Ltd. from 2017 to 2023, Finance Director-Respiratory & Inflammation Area at AstraZeneca PLC from 1998 to 2000, Director-Corporate Communications at Celltech Group Plc, Chief Financial Officer & Non-Executive Director at Glide Pharmaceutical Technologies Ltd., Chief Financial Officer at Verona Pharma Plc from 2013 to 2014, and Chief Operating & Financial Officer at Mereo BioPharma Group Plc.
Education includes an undergraduate degree from The University of Nottingham.